Literature DB >> 23224269

Indications for hospitalization and in-hospital mortality in Thai systemic sclerosis.

Sittichai Netwijitpan1, Chingching Foocharoen, Ajanee Mahakkanukrauh, Siraphop Suwannaroj, Ratanavadee Nanagara.   

Abstract

This study aimed to identify the indications for hospitalization, hospital mortality rate, predictors of hospital mortality, and clinical parameters affecting length of stay (LOS) among Thai systemic sclerosis (SSc). A retrospective study was performed in SSc patients admitted in Khon Kaen University, Thailand, between January 2008 and December 2010. The respective clinical factors affecting LOS and predictors of mortality were analyzed using the Spearman's rank correlation and the Cox regression model. There were 202 hospital admissions among 131 SSc patients. The female-to-male ratio was 1.6:1. The median age at admission was 54.7 years (interquartile range (IQR) 49.2-62.9), the duration of disease at admission was 2.9 years (IQR 1.1-7.8), and the LOS was 5 days (IQR 2-10). The indications for hospitalization were divided equally between SSc-related and non-SSc-related events (53.5 vs. 46.5 %, respectively). The most common indication for hospitalization was infection (23.3 %) and pneumonia is the most common cause of infection (58.0 %). Prolonged LOS was related to fatigability status (p < 0.01), intestinal involvement (p < 0.01), electrolyte disorders (p < 0.01), multiple comorbidities (p < 0.01), modified Rodnan skin score ≥20 points (p = 0.01), disease duration under 5 years (p = 0.02), cardiac arrhythmia (p = 0.04), and deficiency anemia (p = 0.04). Hospital mortality was 16.8 per 100 person-years (95 % confidence interval (95 % CI) 10.8-24.3). Infection (59.1 %) was the most common cause of death, particularly from bacterial pneumonia. Clinical predictors of mortality were: disseminated intravascular coagulation related to infection (hazard ratio (HR) 52.73; 95 % CI 1.26-403.74), cardiac arrhythmia (HR 32.89; 95 % CI 3.00-359.95), electrolyte disorders (HR 15.66; 95 % CI 2.04-119.98), renal crisis (HR 13.38; 95 % CI 1.80-99.36), intestinal involvement (HR 10.42; 95 % CI 2.58-42.01), admission due to a non-SSc-related condition (HR 8.93; 95 % CI 2.21-36.13), and disease duration under 5 years (HR 6.67; 95 % CI 1.21-36.52). Infection was the most common cause of hospitalization. Prolonged LOS and hospital mortality should be warning signs in patients with shorter disease duration, presence of intestinal involvement, cardiac arrhythmia, and multiple comorbidities.

Entities:  

Mesh:

Year:  2012        PMID: 23224269     DOI: 10.1007/s10067-012-2131-0

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  17 in total

Review 1.  Disseminated intravascular coagulation.

Authors:  M Levi; H Ten Cate
Journal:  N Engl J Med       Date:  1999-08-19       Impact factor: 91.245

2.  Scleroderma (systemic sclerosis): classification, subsets and pathogenesis.

Authors:  E C LeRoy; C Black; R Fleischmajer; S Jablonska; T Krieg; T A Medsger; N Rowell; F Wollheim
Journal:  J Rheumatol       Date:  1988-02       Impact factor: 4.666

3.  Prognostic factors of mortality and 2-year survival analysis of systemic sclerosis with pulmonary arterial hypertension in Thailand.

Authors:  Chingching Foocharoen; Ratanavadee Nanagara; Songsak Kiatchoosakun; Siraphop Suwannaroj; Ajanee Mahakkanukrauh
Journal:  Int J Rheum Dis       Date:  2011-06-30       Impact factor: 2.454

Review 4.  Geoepidemiology of systemic sclerosis.

Authors:  Brigitte Ranque; Luc Mouthon
Journal:  Autoimmun Rev       Date:  2009-11-10       Impact factor: 9.754

Review 5.  Epidemiology of systemic sclerosis.

Authors:  Mandana Nikpour; Wendy M Stevens; Ariane L Herrick; Susanna M Proudman
Journal:  Best Pract Res Clin Rheumatol       Date:  2010-12       Impact factor: 4.098

6.  Skin thickness progression rate: a predictor of mortality and early internal organ involvement in diffuse scleroderma.

Authors:  Robyn T Domsic; Tatiana Rodriguez-Reyna; Mary Lucas; Noreen Fertig; Thomas A Medsger
Journal:  Ann Rheum Dis       Date:  2010-08-02       Impact factor: 19.103

7.  Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database.

Authors:  Anthony J Tyndall; Bettina Bannert; Madelon Vonk; Paolo Airò; Franco Cozzi; Patricia E Carreira; Dominique Farge Bancel; Yannick Allanore; Ulf Müller-Ladner; Oliver Distler; Florenzo Iannone; Raffaele Pellerito; Margarita Pileckyte; Irene Miniati; Lidia Ananieva; Alexandra Balbir Gurman; Nemanja Damjanov; Adelheid Mueller; Gabriele Valentini; Gabriela Riemekasten; Mohammed Tikly; Laura Hummers; Maria J S Henriques; Paola Caramaschi; Agneta Scheja; Blaz Rozman; Evelien Ton; Gábor Kumánovics; Bernard Coleiro; Eva Feierl; Gabriella Szucs; Carlos Alberto Von Mühlen; Valeria Riccieri; Srdan Novak; Carlo Chizzolini; Anna Kotulska; Christopher Denton; Paulo C Coelho; Ina Kötter; Ismail Simsek; Paloma García de la Pena Lefebvre; Eric Hachulla; James R Seibold; Simona Rednic; Jirí Stork; Jadranka Morovic-Vergles; Ulrich A Walker
Journal:  Ann Rheum Dis       Date:  2010-06-15       Impact factor: 19.103

8.  Hospitalizations and mortality in systemic sclerosis: results from the Nationwide Inpatient Sample.

Authors:  L Chung; E Krishnan; E F Chakravarty
Journal:  Rheumatology (Oxford)       Date:  2007-11-06       Impact factor: 7.580

9.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

Authors: 
Journal:  Arthritis Rheum       Date:  1980-05

10.  Patterns of hospital admissions and emergency room visits among patients with scleroderma in South Carolina, USA.

Authors:  Paul J Nietert; Richard M Silver
Journal:  J Rheumatol       Date:  2003-06       Impact factor: 4.666

View more
  7 in total

1.  Predictors of inpatient mortality in patients with systemic sclerosis: a case control study.

Authors:  Shiv T Sehra; Andrew Kelly; Joshua F Baker; Chris T Derk
Journal:  Clin Rheumatol       Date:  2016-04-07       Impact factor: 2.980

2.  Reasons for hospitalization and in-hospital mortality in adults with systemic sclerosis: Analysis of the National Inpatient Sample.

Authors:  Joanna Potera; Augustine M Manadan
Journal:  J Scleroderma Relat Disord       Date:  2022-05-11

3.  Population-based analysis of hospitalizations for patients with systemic sclerosis in a West-European region over the period 2001-2012.

Authors:  Matteo Piga; Laura Casula; Silvia Sanna; Daniela Perra; Alberto Floris; Antonello Antonelli; Alberto Cauli; Alessandro Mathieu
Journal:  Rheumatol Int       Date:  2015-07-26       Impact factor: 2.631

Review 4.  An insight into rheumatology in Thailand.

Authors:  Worawit Louthrenoo
Journal:  Nat Rev Rheumatol       Date:  2014-09-09       Impact factor: 20.543

5.  Hospitalisations related to systemic sclerosis and the impact of interstitial lung disease. Analysis of patients hospitalised at the University of Michigan, USA.

Authors:  Shobana Sankar; Mirette Habib; Sara Jaafar; Vivek Nagaraja; David Roofeh; Amber Young; Suiyuan Huang; Dinesh Khanna
Journal:  Clin Exp Rheumatol       Date:  2021-03-10       Impact factor: 4.862

6.  Hospitalisation rates among patients with primary Sjögren's syndrome: a population-based study, 1995-2016.

Authors:  Gabriel Maciel; Luisa Servioli; Carlotta Nannini; Alvise Berti; Cynthia S Crowson; Sara J Achenbach; Eric L Matteson; Divi Cornec
Journal:  RMD Open       Date:  2018-02-28

7.  Assessment of hospitalization and mortality of scleroderma in-patients: a thirteen-year study.

Authors:  Saeedeh Shenavandeh; Razieh Naseri
Journal:  Reumatologia       Date:  2017-08-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.